Carfilzomib, Pegylated Liposomal Doxorubicin Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT01246063 · COMPLETED
Trial details
- NCT number
- NCT01246063
- Sponsor
- Washington University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-14
- Primary completion
- 2017-12-28
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.